1. Home
  2. HUBCW vs SLRX Comparison

HUBCW vs SLRX Comparison

Compare HUBCW & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBCW
  • SLRX
  • Stock Information
  • Founded
  • HUBCW N/A
  • SLRX N/A
  • Country
  • HUBCW Israel
  • SLRX United States
  • Employees
  • HUBCW 322
  • SLRX N/A
  • Industry
  • HUBCW
  • SLRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUBCW
  • SLRX Health Care
  • Exchange
  • HUBCW Nasdaq
  • SLRX Nasdaq
  • Market Cap
  • HUBCW N/A
  • SLRX 1.8M
  • IPO Year
  • HUBCW N/A
  • SLRX N/A
  • Fundamental
  • Price
  • HUBCW $0.02
  • SLRX $0.75
  • Analyst Decision
  • HUBCW
  • SLRX
  • Analyst Count
  • HUBCW 0
  • SLRX 0
  • Target Price
  • HUBCW N/A
  • SLRX N/A
  • AVG Volume (30 Days)
  • HUBCW N/A
  • SLRX 3.6M
  • Earning Date
  • HUBCW N/A
  • SLRX 08-08-2025
  • Dividend Yield
  • HUBCW N/A
  • SLRX N/A
  • EPS Growth
  • HUBCW N/A
  • SLRX N/A
  • EPS
  • HUBCW N/A
  • SLRX N/A
  • Revenue
  • HUBCW N/A
  • SLRX N/A
  • Revenue This Year
  • HUBCW N/A
  • SLRX N/A
  • Revenue Next Year
  • HUBCW N/A
  • SLRX N/A
  • P/E Ratio
  • HUBCW N/A
  • SLRX N/A
  • Revenue Growth
  • HUBCW N/A
  • SLRX N/A
  • 52 Week Low
  • HUBCW N/A
  • SLRX $0.45
  • 52 Week High
  • HUBCW N/A
  • SLRX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • HUBCW N/A
  • SLRX 41.73
  • Support Level
  • HUBCW N/A
  • SLRX $0.66
  • Resistance Level
  • HUBCW N/A
  • SLRX $0.90
  • Average True Range (ATR)
  • HUBCW 0.00
  • SLRX 0.12
  • MACD
  • HUBCW 0.00
  • SLRX -0.03
  • Stochastic Oscillator
  • HUBCW 0.00
  • SLRX 16.46

About HUBCW Hub Cyber Security Ltd. Warrant 2/27/28

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Share on Social Networks: